Viewing Study NCT01084356


Ignite Creation Date: 2025-12-24 @ 11:25 PM
Ignite Modification Date: 2025-12-31 @ 11:29 PM
Study NCT ID: NCT01084356
Status: UNKNOWN
Last Update Posted: 2010-03-10
First Post: 2010-03-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of a New CZT System
Sponsor: Tel-Aviv Sourasky Medical Center
Organization:

Study Overview

Official Title: Evaluation of a New CZT System for Imaging in Routine Nuclear Medicine Examination
Status: UNKNOWN
Status Verified Date: 2010-03
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of the study is to check if the new CZT system has an advantage in detection of small osseous processes, thyroid adenomas, parathyroid adenomas and detection of sentinel node, in comparison with the techniques in use.

Participants: 100 subjects male and female that come to the institute of nuclear medicine for routine screening examinations.

The CZT screening takes 10 minutes and does not require any extra intervention to the routine screening.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: